XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information - Research and development costs and an allocation of indirect research and development costs to each program (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
Segment Information        
Number of operating segments | segment     1  
Number of reportable segments | segment     1  
Total R&D Expense $ 62,931 $ 45,263 $ 169,741 $ 116,611
Single reportable segment        
Segment Information        
Total R&D Expense 62,931 45,263 169,741 116,611
Single reportable segment | Barzolvolimab/Anti-KIT Program        
Segment Information        
Total R&D Expense 51,619 34,393 133,967 88,643
Single reportable segment | CDX-622        
Segment Information        
Total R&D Expense 5,617 3,628 14,906 10,175
Single reportable segment | Other Programs        
Segment Information        
Total R&D Expense $ 5,695 $ 7,242 $ 20,868 $ 17,793